File
| Expiration Date | FOA Title | FOA Number/URL | Release Date | Research Category |
|---|---|---|---|---|
| 7/15/2022 | Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) | PAR-20-164 | 4/3/2020 | Health Disparities |
| 9/8/2022 | Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity | NOT-NS-20-024 | 5/5/2020 | Bilateral Program |
| none | Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) | NOT-MD-21-016 | 2/23/2021 | Health Disparities |
| 12/12/2023 | Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-21-251 | 9/8/2021 | Global Health |
| 12/12/2023 | Emerging Global Leader Award (K43 Independent Clinical Trial Not Required) | PAR-21-252 | 9/8/2021 | Global Health |
| 12/12/2023 | Global Brain and Nervous System Disorders Research Across the Lifespan (R21) | PAR-21-319 | 9/13/2021 | Global Health |
| 12/12/2023 | Global Brain and Nervous System Disorders Research Across the Lifespan (R01, PAR-21-311) | PAR-21-311 | 9/13/2021 | Global Health |
| 7/14/2023 | Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) | PAR-21-230 | 5/24/2021 | Global Health |
| 2/1/2024 | Notice of Special Interest (NOSI): Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional) | NOT-OD-22-032 | 12/2/2021 | Health Disparities |
| 7/16/2024 | Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) | PAR-22-104 | 3/11/2022 | Global Health |
| 8/11/2022 | Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs)and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional) | PAR-22-132 | 3/30/2022 | Global Health |